Fusion Antibodies plc

Company Profile

Company website

www.fusionantibodies.com

Sector

Health Care Providers (Health Care Services)

Description

Fusion Antibodies plc (AIM: FAB) is a contract research organisation providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

Latest Company
Presentation

Latest Company Summary

Investor Access

05 Dec

Event information

Management will announce its unaudited interim results for the six months ended 30 September 2022 on Monday 5^th December 2022.

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Friday 9^th December 2022 at 10:00 relating to its interim results for the six months ended 30 September 2022. Investors can sign up to Investor Meet Company for free, by clicking: https://www.investormeetcompany.com/fusion-antibodies-plc/register-investor

Venue

Online

Time

Monday 5^th December 2022

Financial Calendar

Event	Date
Year End	31 March
Half Year End	30 September
Preliminary Results*	August
Interim Results*	November
AGM*	September

* Months based on previous announcements of this kind

Latest Corporate Video

Walbrook Latest News

Walbrook PR - Zamaz plc

20 September 2022

Walbrook PR, which provides high quality Financial PR and Investor Relations to Small Cap and AIM listed companies, announces it is acting as Financial PR & Investor Relations advisor for Zamaz plc (LSE:ZAMZ), the on-line consumer goods business that originates, acquires or licenses, operates and scales small and medium-sized brands with category-winning products on global marketplaces; with a focus on ecologically produced, ethically, and health supportive brands and products. Walbrook is managing the Company’s ongoing communications with the financial media, research analysts and non-institutional investors, including new and existing private investors.

https://twitter.com/WalbrookPR

Walbrook Tweets

Tweets by WalbrookPR